USD
0.00
(0.00%
)AT CLOSE (AS OF Aug 15, 2025)
$4M
MARKET CAP
-
P/E Ratio
-2.14
EPS
$3
52 Week High
$0.56
52 Week Low
LIFE SCIENCES
Sector
Automate your trading workflow with powerful tools — built for serious traders.
Field | Value (USD) |
---|---|
Gross Profit | -$212K |
Total Revenue | $0 |
Cost Of Revenue | $212K |
Costof Goods And Services Sold | $212K |
Operating Income | -$19M |
Selling General And Administrative | $9.6M |
Research And Development | $8.3M |
Operating Expenses | $19M |
Investment Income Net | - |
Net Interest Income | $1.9M |
Interest Income | $1.9M |
Interest Expense | $13K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $212K |
Income Before Tax | -$18M |
Income Tax Expense | -$1 |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$18M |
Comprehensive Income Net Of Tax | - |
Ebit | -$18M |
Ebitda | -$18M |
Net Income | -$18M |
Field | Value (USD) |
---|---|
Total Assets | $25M |
Total Current Assets | $25M |
Cash And Cash Equivalents At Carrying Value | $8.8M |
Cash And Short Term Investments | $8.8M |
Inventory | - |
Current Net Receivables | $44K |
Total Non Current Assets | $161K |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $16M |
Other Current Assets | $90K |
Other Non Current Assets | - |
Total Liabilities | $1.3M |
Total Current Liabilities | $1.3M |
Current Accounts Payable | $141K |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | - |
Total Non Current Liabilities | $0 |
Capital Lease Obligations | $0 |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | - |
Other Current Liabilities | $1.2M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $24M |
Treasury Stock | - |
Retained Earnings | -$145M |
Common Stock | $84M |
Common Stock Shares Outstanding | $5.8M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$17M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $212K |
Capital Expenditures | $83K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | $21M |
Cashflow From Financing | $0 |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$18M |
Field | Value (USD) |
---|---|
Gross Profit | -$212K |
Total Revenue | $0 |
Cost Of Revenue | $212K |
Costof Goods And Services Sold | $212K |
Operating Income | -$19M |
Selling General And Administrative | $9.6M |
Research And Development | $8.3M |
Operating Expenses | $19M |
Investment Income Net | - |
Net Interest Income | $1.9M |
Interest Income | $1.9M |
Interest Expense | $13K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $212K |
Income Before Tax | -$18M |
Income Tax Expense | -$1 |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$18M |
Comprehensive Income Net Of Tax | - |
Ebit | -$18M |
Ebitda | -$18M |
Net Income | -$18M |
Sector: LIFE SCIENCES
Industry: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS
Check-Cap Ltd., a clinical-stage medical diagnostics company, is developing a capsule-based system that uses low-dose X-rays to scan the inner lining of the colon for precancerous polyps and other structural abnormalities in Israel. . The company is headquartered in Isfiya, Israel.
Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.